8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 21, 2011

ROCHESTER MEDICAL CORPORATION

(Exact name of registrant as specified in its charter)

Minnesota	0-18933	41-1613227
(State or other jurisdiction of incorporation)	(Commission file number)	(I.R.S. Employer Identification No.)

One Rochester Medical Drive, Stewartville, MN 55976

(Address of principal executive offices)

Registrant’s telephone number, including area code: (507) 533-9600

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

On December 21, 2011, the Board of Directors of Rochester Medical Corporation accepted the retirement of Roger W. Schnobrich from the Board of Directors, effective upon conclusion of the Company’s 2012 Annual Meeting of Shareholders, as presented in a press release dated December 23, 2011.

The Nominating Committee (the “Committee”) of the Board is responsible for recommending to the Board of Directors of the Company director nominees for election by the shareholders at the next annual meeting. The Committee has nominated Peter H. Shepard as a new director candidate for election at the Company’s 2012 Annual Meeting of Shareholders, to fill the vacancy created by the retirement of Mr. Schnobrich and to serve for a term expiring at the Company’s next Annual Meeting of Shareholders or until his successor is duly elected and qualified. Biographical information regarding Mr. Shepard is included in the Company’s proxy statement in connection with its 2012 Annual Meeting of Shareholders, as filed with the Securities and Exchange Commission on December 23, 2011. Upon his election to the Board by the shareholders of the Company, Mr. Shepard is expected to serve on the Audit, Compensation and Nominating Committees.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press release of the Company, dated December 23, 2011.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Date: December 23, 2011

ROCHESTER MEDICAL CORPORATION
By:	/s/ David A. Jonas
	David A. Jonas Chief Financial Officer

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press release of the Company, dated December 23, 2011

EX-99.1

Exhibit 99.1

Rochester Medical Director Schnobrich to Retire

Stewartville, MN December 23, 2011.

Rochester Medical Corporation (NASDAQ: ROCM) announced today that Roger W. Schnobrich will retire from its Board of Directors following the conclusion of the Company’s 2012 Annual Meeting of Shareholders to be held on January 26, 2012, which is the end of his current term.

Board Chairman and CEO Anthony J. Conway stated that “Mr. Schnobrich has served on our Board since 1995. His cheerful intelligence and gracious temperament have served the Company well. He is a man of excellent character and dignity, and Rochester Medical Corporation has benefited greatly from these traits over the years.

“Our many thanks for working with us, Roger. I know you will continue to enjoy each day.”

Conway continued, “I am very pleased to announce that the Board of Directors has nominated Peter H. Shepard for election as a Director for Rochester Medical Corporation at the 2012 Annual Meeting. Mr. Shepard has deep knowledge and experience in the medical device industry and is particularly expert in the field of Urology and Incontinence. Mr. Shepard’s extensive sales and marketing experience will enable him to provide valuable insight and guidance to our management team with respect to our strategic initiatives to grow sales domestically and internationally.”

About Rochester Medical Corporation

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications. The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or Parice Halbert, CFA, at Westwicke Partners (443) 213-0500. More information about the 2012 Annual Meeting of Shareholders is included in the Company’s proxy statement filed with the Securities and Exchange Commission on December 23, 2011. More information about Rochester Medical is available on its website at http://www.rocm.com.